Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is….
Get Rs 2 lakh insurance for just a cost of two tea cups. Know about Pradhan Mantri Suraksha Bima Yojana here.
By Joy Pillai Edited by Joy Pillai
Advertisement
Good news! Now you can get insurance for low price, get Rs 2 lakh cover for only Rs 20 in this govt scheme, name is....
Pradhan Mantri Suraksha Bima Yojana: Many people have a habit of drinking tea and smoking cigarettes. This habit affects health and, in the long run, causes serious diseases. But what if we tell you that you can buy insurance worth Rs 2 lakh just by skipping two cups of tea or a cigarette? Today, we are telling you about an insurance scheme that provides financial security at a very low premium. No, it is not a fraud scheme, and there are no hidden charges either, because the scheme is run by the Government of India. The name of this scheme is Pradhan Mantri Suraksha Bima Yojana (PMSBY). Let's know more about the scheme.
What Is Pradhan Mantri Suraksha Bima Yojana?
Pradhan Mantri Suraksha Bima Yojana is basically an accident insurance scheme which offers accidental death and disability cover on account of an accident. The aim of the scheme is to provide financial strength to economically weaker families. The premium under PMSBY is only Rs. 20 per year. Under this scheme, you can also deposit a premium of Rs. 2 every month. Under this scheme, this amount is deducted from your Aadhaar linked bank account every year.
Advertisement ===
Key Features Of PMSBY
If the insured person becomes completely disabled in an accident, then he is eligible to get Rs 2 lakh.
In case of a partial accident, Rs 1 lakh is given under the scheme.
Advertisement ===
The insurance can be renewed every year.
If the policyholder dies, then this money is given to the family.
Who Can Avail The Benefit?
People between the ages of 18 to 70 can avail themselves of the benefits of the scheme. Notably, this policy ends automatically on completion of the age of 70 years.
Only Indian citizens are eligible for the security insurance scheme.
The applicant must have an active bank account in any bank, which is linked to Aadhaar.
If your bank account is closed then this policy will also end.
The policy cover period is between 1st June to 31st May.
What Is The Process Of Applying?
To apply for this insurance program, apply at your bank. The bank will provide an application form which, once completed and submitted with the required documents, will initiate the process.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
3 hours ago
- New Indian Express
Around 30 per cent of Indians at risk of obesity: CCMB Study
HYDERABAD: Long-term tracking of thousands of healthy Indian individuals has revealed that 25 per cent to 30 per cent became obese by adulthood, even though they showed no signs of the condition at the beginning. This finding is part of a global study that offers new genetic insights into obesity and introduces a polygenic risk score (PRS) capable of predicting the likelihood of developing obesity as early as age five. The study involved over 600 scientists across 500 institutions, including researchers from Hyderabad-based CSIR-CCMB. Led by senior geneticist Dr. Giriraj Ratan Chandak, CSIR-CCMB contributed to ensuring that the genetic data from Indian participants reflected South Asian diversity. Dr. Chandak told TNIE, 'The study included four Indian cohorts, mainly from Mysore, Mumbai, and Pune, ranging from 2,200 to over 20,000 individuals, many of whom have been followed for nearly two decades. The long-term data allowed researchers to assess how genetics and lifestyle together influence obesity progression over a lifetime.' The study also found that individuals with a higher genetic risk are more prone to obesity but tend to respond better to lifestyle interventions, although they may regain weight more quickly when those interventions are discontinued.
The Hindu
3 hours ago
- The Hindu
India joins international support campaign for Bangladesh after air force jet crashed in Dhaka
The Government of India on Tuesday (July 22, 2025) reached out to Bangladesh offering assistance to deal with the aftermath of the tragic crash of an aircraft from the Bangladesh Air Force that led to the death of at least 20 students and teachers and injury for more than a hundred others in a school in capital Dhaka. In a statement, the Ministry of External Affairs announced that a team of doctors will be visiting Bangladesh soon. 'A team of burn-specialist doctors and nurses with necessary medical support are scheduled to visit Dhaka shortly to treat the victims. They will make an assessment of the condition of patients with recommendation for further treatment and specialized care in India as necessary. Additional medical teams may also follow depending on their preliminary assessement and treatment,' said the Ministry of External Affairs in a statement on Tuesday. The crash took place on Monday (July 21, 2025) when a Chinese-made aircraft crashed in the school where students and teachers were getting ready for the day ahead. Subsequently, India, China and Japan were among the first countries to offer support to Bangladesh. Foreign Affairs Adviser of the interim government, Touhid Hossein said, 'As of now, we require doctors, nurse, some special medicines, and some emergency medicine equipment – Accordingly we will seek assistance from these three countries.'
Time of India
3 hours ago
- Time of India
KGMU study offers new relief options for chronic heel pain
Lucknow: People suffering from persistent heel pain may soon have better relief options through regenerative medicine, shows a recent study by King George's Medical University. The study, 'Ultrasonography-guided dextrose prolotherapy versus platelet-rich plasma injections for the treatment of Plantar Fasciitis', was published in the journal Cureus in Feb. Researchers from KGMU's physical medicine and rehabilitation (PMR) department found two regenerative methods — dextrose prolotherapy and platelet-rich plasma (PRP) injections. Lead researcher Prof Sudhir Mishra said that chronic heel pain is due to damage to the thick tissue under the foot and often difficult to treat with conventional methods. This affects about 10% of people, especially women in 40-60 age group and athletes. Traditional treatments like rest, stretching, orthotics, corticosteroids and physical therapy often help, but many patients still experience pain. The study involved 44 patients unresponsive to standard treatments. They were split into two groups — one received ultrasound-guided 25% dextrose injections, the other PRP from their own blood. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cat Keeps Hugging Friend Before Going To The Vet – The Vet Paled When He Saw Them Tips and Tricks Undo After six weeks, both groups reported less pain and improved foot and ankle function. PRP showed slightly better results, but differences were not always significant. Prof Mishra said these minimally invasive injections are well tolerated and can greatly improve the quality of life for patients who do not respond to conventional treatments. Although PRP is more costly and complex to prepare, both treatments are safe, effective and can be chosen based on patient needs. The study supports growing evidence for regenerative medicine in chronic musculoskeletal pain. Physical medicine and rehabilitation department head, Prof Anil Kumar Gupta, said treatment usually starts with rest, special insoles and sometimes steroid injections, which work well in early or mild cases. When traditional methods fail, regenerative therapies like dextrose prolotherapy and PRP are considered. Both stimulate tissue repair — dextrose needs multiple injections and lasts shorter, while PRP often requires a single injection and lasts longer. Prof Mishra said dextrose costs about Rs 500-700 per session, including ultrasound guidance, making it more affordable. PRP costs Rs 3,000-3,500 due to specialised processing but requires fewer sessions. PRP is especially effective for long-term pain lasting months or more. Using the patient's own blood lowers allergy risks and can work when other treatments fail. Choice depends on pain duration and severity. For pain lasting a week or two, traditional methods suffice. For pain over a month, dextrose prolotherapy may be advised. For pain lasting three months or more, especially if other treatments fail, PRP is preferred. Dextrose typically requires 2-3 injections spaced 15 days apart, while PRP usually needs one injection, with a second dose for severe cases. Both are effective, but PRP tends to offer better pain relief and longer recovery.
